SELECT PUBLICATIONS

Ames F et al. Tumor location and nodal drainage patterns on lymphoscintigraphy are predictors of axillary sentinel lymph node status. Proc ASCO 2001; Abstract 155.

Bevilacqua JLB et al. Detection of axillary node positivity is increased with sentinel lymph node biopsy in early stage breast carcinoma. Breast Cancer Res Treat 2000; Abstract 104.

Bevilacqua JLB et al. The first 2,000 cases — axillary node metastases in the sentinel lymph node era. Breast Cancer Res Treat 2000; Abstract 105.

Breslin TM et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 2000;18:3480-6. Abstract

Chetty U et al. Management of the axilla in operable breast cancer treated by breast conservation: A randomized clinical trial. Edinburgh Breast Unit. Br J Surg 2000;87:163-9. Abstract

Cody HS 3rd.Clinical aspects of sentinel node biopsy. Breast Cancer Res. 2001;3:104-8. Abstract

Dessureault S et al. Early results of breast cancer lymphatic mapping from the H Lee Moffitt Cancer Center: No axillary recurrences in breast cancer patients after a negative sentinel lymph node biopsy. Breast Cancer Res Treat 2000;Abstract 1.

Edge SB et al. Rapid implementation of sentinel node biopsy for breast cancer at cancer centers. Proc ASCO 2001; Abstract 153.

Fisher B et al. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Eng J Med 1985;312:674-681. Abstract

Gemignani ML, Borgen PI. Is there a role for selective axillar y dissection in breast cancer? World J Surg. 2001;25:809-18. Abstract

Grube BJ et al. A decade of sentinel lymph node mapping in breast cancer: A hypothesis-driven journey toward a new paradigm. Poster, 2001 Miami Breast Cancer Conference. Full-Text

Hansen NM et al. Clinical significance of axillary micrometastases in breast cancer: How small is too small? Proc ASCO 2001;Abstract 91.

Keshtgar MR, Baum M. Axillary dissection over the years: Where to from here? World J Surg 2001;25:761-6. Abstract

Krag D. Minimal invasive staging for breast cancer: Clinical experience with sentinel lymph node biopsy. Semin Oncol 2001;28:229-35. Abstract

Haigh PI et al. Surgery for diagnosis and treatment: Sentinel lymph node biopsy in breast cancer. Cancer Control 1999;6(3):301-306. Full-Text

Hsueh EC et al. Intraoperative lymphatic mapping and sentinel lymph node dissection in breast cancer. CA Cancer J Clin 2000;50(5):279-91. Full-Text

Lambah PA et al. Long term results of randomised studies of axillary clearance vs non-targeted axillary sampling. Breast Cancer Res Treat 2000;Abstract 109.

Mansel RE. The UK Almanac Trial (MRC) - Early Results. Poster, 2001 Miami Breast Cancer Conference. Full-Text

Mateos JJ et al. Sentinel lymph node biopsy in breast cancer patients: Subdermal versus peritumoural radiocolloid injection. Nucl Med Commun 2001;22:17-24. Abstract

Morrow M et al. Learning sentinel node biopsy: Results of a prospective randomized trial of two techniques. Surgery 1999;126(4):714-20; discussion 720-2. Abstract

Nieweg OE et al. Is lymphatic mapping in breast cancer adequate and safe? World J Surg 2001;25:780-8. Abstract

Noguchi M. Sentinel lymph node biopsy as an alternative to routine axillary lymph node dissection in breast cancer patients. J Surg Oncol 2001;76:144-56. Abstract

O'Sullivan M et al. Preliminary results of changes in the quality of life in patients undergoing sentinel lymph node mapping or axillary clearance for early breast cancer. Proc ASCO 2001;Abstract 1900.

Owen DH. The Intradermal Sentinel Node: Update 2000. Poster, 2001 Miami Breast Cancer Conference. Full-Text

Reynolds C et al. Sentinel lymph node biopsy with metastasis: Can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 1999;17:1720-6. Abstract

Rodier JF et al. Lymphatic mapping and sentinel node biopsy of operable breast cancer. World J Surg 2000;24:1220-5; discussion 1225- 6. Abstract

Sakorafas GH. Breast cancer surgery--historical evolution, current status and future perspectives. Acta Oncol 2001;40:5-18. Abstract

Singletary SE. Systemic treatment after sentinel lymph node biopsy in breast cancer: Who, what and why? J Am Coll Surg 2001;192:220-30. Abstract

Tafra L et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 2001;233:51-9. Abstract

Veronesi U et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: Results in a large series. J Natl Cancer Inst 1999;91:368-73. Abstract

Wayne JD et al. Anaphylactic reaction to isosulfan blue dye (IBD) during sentinel lymph node biopsy (SLNB) is more common in breast cancer than in melanoma. Proc ASCO 2001;Abstract 150.

Weaver DL. Sentinel lymph node biopsy in breast cancer: Creating controversy and defining new standards. Adv Anat Pathol 2001;8:65- 73. Abstract

Wong SL et al. Sentinel lymph node biopsy for breast cancer: Impact of the number of sentinel nodes removed on the false-negative rate. J Am Coll Surg 2001;192:684-9; discussion 689-91. Abstract

Woolam GL. What's new in breast cancer surgery? CA Cancer J Clin 2000; 50(5):276-8. Full-Text

Top

OTHER RESOURCES

Beitsch PS. SLNB slide presentation with photographs of the procedure. Web link

Comprehensive NCI patient education monograph on SLNB: Includes review of NSABP and ACOS trials. Web link

Top

Additional Sections:
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 |

Additional Sections: